Rifaximin Alleviates Endotoxemia with Decreased Serum Levels of Soluble CD163 and Mannose Receptor and Partial Modification of Gut Microbiota in Cirrhotic Patients

Rifaximin is a poorly absorbable antibiotic against hepatic encephalopathy (HE). This observational study aimed to elucidate the effect of rifaximin on intestinal permeability and gut microbiota in patients with decompensated cirrhosis. Thirty patients with decompensated cirrhosis were assessed by a...

Full description

Saved in:
Bibliographic Details
Published in:Antibiotics (Basel)
Main Authors: Kaji, Kosuke, Saikawa, Soichiro, Takaya, Hiroaki, Fujinaga, Yukihisa, Furukawa, Masanori, Kitagawa, Koh, Ozutsumi, Takahiro, Kaya, Daisuke, Tsuji, Yuki, Sawada, Yasuhiko, Kawaratani, Hideto, Moriya, Kei, Namisaki, Tadashi, Akahane, Takemi, Mitoro, Akira, Yoshiji, Hitoshi
Format: Artigo
Language:Inglês
Published: MDPI 2020
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7235723/
https://ncbi.nlm.nih.gov/pubmed/32235367
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antibiotics9040145
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items